• Replacement techniques to reduce animal experiments in drug and nanoparticle development

• Jin Ik-Sup

• Yoon Moon-Sup, Park Chun-Woong, Hong Jin-Tae, Chung Youn-Bok, Kim Jin-Seok, Shin Dae-Hwan

• Journal of Pharmaceutical Investigation   2020  Volume.50  No.3 327 ~ 335

• Gene regulations and delivery vectors for treatment of cancer

• Chen Ming

• Ren Yu-Xin, Xie Ying, Lu Wan-Liang

• Journal of Pharmaceutical Investigation   2020  Volume.50  No.3 309 ~ 326

• Recent advances in the formulation of sphingolipid anticancer therapeutics

• Choi Min-Koo

• Song Im-Sook

• Journal of Pharmaceutical Investigation   2020  Volume.50  No.3 295 ~ 307

• Mitochondrial targeted strategies and their application for cancer and other diseases treatment

• Li Qiuyi

• Huang Yuan

• Journal of Pharmaceutical Investigation   2020  Volume.50  No.3 271 ~ 293

• Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment

• Tran Phuong

• Lee Sang-Eun, Kim Dong-Hyun, Pyo Yong-Chul, Park Jeong-Sook

• Journal of Pharmaceutical Investigation   2020  Volume.50  No.3 261 ~ 270

• Factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays

• Gao Mingyue

• Shen Xin, Mao Shirui

• Journal of Pharmaceutical Investigation   2020  Volume.50  No.3 251 ~ 259

• Application of diethylene glycol monoethyl ether in solubilization of poorly water-soluble drugs

• Ha Eun-Sol

• Lee Seon-Kwang, Choi Du-Hyung, Jeong Seong-Hoon, Hwang Sung-Joo, Kim Min-Soo

• Journal of Pharmaceutical Investigation   2020  Volume.50  No.3 231 ~ 250

• Emerging nanoparticulate drug delivery systems of metformin

• Chen Yao

• Shan Xinzhu, Luo Cong, He Zhonggui

• Journal of Pharmaceutical Investigation   2020  Volume.50  No.3 219 ~ 230